📋 Tender Overview
Eurofins Scientific EUFI.PA a global scientific leader in bioanalytical testing announces that it has successfully signed an agreement with Stichting PAMM Laboratoria voor Pathologie en Medische Microbiologie PAMM a medical microbiology and pathology laboratory diagnostics company in The Netherlands.PAMM serves 6 hospitals in The Netherlands including 2 top-rated clinical oncology centers general practitioners and independent treatment centers. The lab specializes in medical microbiology and pathology and was the first in The Netherlands to have implemented full digital pathology. PAMM employs over 265 employees and pathologists and will complement Eurofins industry-leading global clinical testing offering. Through combining forces PAMM will be able to further improve quality to clients and service to patients in the Dutch healthcare system.The agreement includes a commitment by Eurofins to invest in the laboratory RD innovation employee development and job security. The agreement has been approved by the Dutch Healthcare authority NZa and The Netherlands Authority for Consumers and Markets ACM Merger Control.Comment from Dr. Gilles Martin Eurofins CEO We are very pleased to welcome PAMM and its team of outstanding specialists and laboratory technicians to the Eurofins Group. This agreement reinforces the Groups broad innovative test offering to hospitals and practitioners in The Netherlands strengthens Eurofins geographic offering in the clinical testing market and enhances our ability to deploy the latest scientific advances to benefit patients.
